Literature DB >> 3934914

Malignant hyperthermia triggered by heating in anaesthetized pigs.

H Ording, A Hald, E Sjøntoft.   

Abstract

Three malignant hyperthermia susceptible (MHS) and three normal Danish landrace pigs were heated using a water-heated mattress, warm blankets and warm intravenous saline during anaesthesia with barbiturate and 50% nitrous oxide in oxygen. The MHS pigs developed typical malignant hyperthermia (MH) at a rectal temperature of 41.0 +/- 0.7 degrees C, whereas the normal pigs tolerated heating to the same temperature without any ill effects. Haemodynamic and metabolic findings during MH were similar to those previously reported for anaesthetic-induced MH in pigs. Heat intolerance may thus be one factor in the genesis of MH.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3934914     DOI: 10.1111/j.1399-6576.1985.tb02283.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  4 in total

1.  Rewarming following hypothermic cardiopulmonary bypass in the malignant hyperthermia-susceptible patient: implications for diagnosis and perioperative management.

Authors:  G C Allen; C B Cattran
Journal:  Can J Anaesth       Date:  1989-01       Impact factor: 5.063

Review 2.  Etiopathogenetic defect of malignant hyperthermia: hypersensitive calcium-release channel of skeletal muscle sarcoplasmic reticulum.

Authors:  P J O'Brien
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

3.  Anesthetic- and heat-induced sudden death in calsequestrin-1-knockout mice.

Authors:  Marco Dainese; Marco Quarta; Alla D Lyfenko; Cecilia Paolini; Marta Canato; Carlo Reggiani; Robert T Dirksen; Feliciano Protasi
Journal:  FASEB J       Date:  2009-02-23       Impact factor: 5.191

4.  Lessons from calsequestrin-1 ablation in vivo: much more than a Ca(2+) buffer after all.

Authors:  Feliciano Protasi; Cecilia Paolini; Marta Canato; Carlo Reggiani; Marco Quarta
Journal:  J Muscle Res Cell Motil       Date:  2011-12-01       Impact factor: 2.698

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.